Oranga Rongo Papakura Marae Centre Figure 3 Male Diagnosed Gout - - PowerPoint PPT Presentation

▶
oranga rongo
SMART_READER_LITE
LIVE PREVIEW

Oranga Rongo Papakura Marae Centre Figure 3 Male Diagnosed Gout - - PowerPoint PPT Presentation

Dec 01, 2023 193 likes •359 views

Oranga Rongo Papakura Marae Centre Figure 3 Male Diagnosed Gout Prevalence by age and ethnicity National prevalence of gout derived from administrative health data in Aotearoa New Zealand Winnard D; Wright C; Taylor W; Jackson G; Te Karu

slide-1
SLIDE 1

Oranga Rongoā

Papakura Marae Centre

slide-2
SLIDE 2

Figure 3 Male Diagnosed Gout Prevalence – by age and ethnicity

0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% 20-24 Years 25-29 Years 30-34 Years 35-39 Years 40-44 Years 45-49 Years 50-54 Years 55-59 Years 60-64 Years 65-69 Years 70-74 Years 75-79 Years 80-84 Years 85+ Years 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% Asian Maori European/Other Pacific All

National prevalence of gout derived from administrative health data in Aotearoa New Zealand

Winnard D; Wright C; Taylor W; Jackson G; Te Karu L; Gow P; Arroll B; Thornley S; Gribben B; Dalbeth N Rheumatology 2012;51:901-9.

slide-3
SLIDE 3

C

Gout Demands

What is gout? What causes gout? Recognsing signs and symptoms of gout attack Judging the severity of gout attack What to do for a gout attack (getting help) Identifying causes of gout attacks The role of the kidneys The role of genes 80/20 rule Medicines (types and what they do) Medicines (serious side effects) Uric aciid medicines - titration Purine rich food and drinks Uric acid target and monitoring (0.36) Risk of comorbidities Access & cost

  • f healthcare

Communicating with healthcare professionals Talking to your family, friends and workmates Preventing gout

slide-4
SLIDE 4

Treatment to Target

  • Where we started
  • Today
slide-5
SLIDE 5

Treatment to Target

  • Comparison
  • ~6 % of U.S Population have gout managed

according to Guidelines

(N. L Edwards Curr Rheumatol Rep (2011) 13:154–159)

  • 414 patients, 51% were treated with allopurinol 33.6%

had ever had serum urate level tested 6.7% of people were achieving target serum urate levels

(B. Arroll et al., 2011)

slide-6
SLIDE 6

Treating with Allopurinol

  • Where we started
  • Today
slide-7
SLIDE 7

Classification – from ...to

slide-8
SLIDE 8

Patients with Gout classification

  • n Allopurinol
slide-9
SLIDE 9

Urate Testing

slide-10
SLIDE 10

The next tier

slide-11
SLIDE 11

Care planning

  • Improving health literacy
  • Cultural competency,
  • Motivational interviewing,
  • Having difficult conversations,
  • Recognising and acting on change talk.
  • Equalising power imbalances
  • Using technology to support patient education and

information e.g. patient portal

  • Utilising patient stories and patient journeys
slide-12
SLIDE 12
slide-13
SLIDE 13

Patient Perspective

  • I don’t have gout
  • Haven't had gout for ages
slide-14
SLIDE 14

Project Aim

  • Changes with patient input

– Want easy access allopurinol – No flares

slide-15
SLIDE 15